J. Lu

A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.

P. Malfertheiner, H. Friess, E. Van Cutsem, 2008, The journal of supportive oncology.

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.

D. Grignon, W. Shipley, J. Cox, 2000, International journal of radiation oncology, biology, physics.

Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.

P. Grigsby, D. Mutch, J. Lu, 1998, International journal of radiation oncology, biology, physics.

RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate

S. Rosenthal, G. Hanks, V. Venkatesan, 2000 .

Long-term survival after radiotherapy alone: radiation therapy oncology group prostate cancer trials.

D. Grignon, M. Roach, M. Mohiuddin, 1999, The Journal of urology.